Bin Wu - Profile and Investment Details

Investor Profile

Bin Wu is a Private Equity Firm based in Beijing, China with a diverse investment portfolio that includes companies such as MicroPort Medbot, Enflame, Fengbang Leasing, Jiaanpei, Zhongce Che Kongjian, FXiaoKe, Green A, Yuanfudao, 4Paradigm, 3D Medicines, Terminus Technologies, Chuangmi Technology, Cheyipai, Hanyu Medical, VANCL, Kunlun, MicroPort EPTouch, Shanghai ANE Logistics, DuerOS, Adaps Photonics, JD Health, New China Life Insurance, ELEME, guanaitong.com, Fiture, DiDi Autonomous Driving, Deerma, Jaka Robot, Pony.ai, Shaanxi Xifeng Liquor Co,.LTD, G-NET, 17zuoye, Horizon Robotics, Biotheus, CStone Pharmaceuticals, Fenbi, JW Therapeutics, CHINA UNION LOYALTY, MicroPort CardioFlow, Wangjiahuan, China UnionPay Merchant Services, ofo, Mango Excellent Media, Best, Inc., ThreatBook, . Over time, Bin Wu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bin Wu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Cybersecurity, Sports, Wellness, Transportation, Banking, Education, Artificial Intelligence (AI), Robotics, Finance, Biotechnology, Food and Beverage, Agriculture, Hardware, Logistics, Vocational Education, Medical, Big Data, Machine Learning, Business Intelligence may find it worthwhile to explore potential connections with Bin Wu, as their portfolio suggests a familiarity and interest in this area.

Understanding Bin Wu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.